Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-07 | 2026-08-11 | Canning John Charles | Chief Operating Officer | Purchase | 4,375 | $3.20 | $14K | 4,375 | View | |
| 2026-08-07 | 2026-08-11 | Elefant Dov | Chief Financial Officer | Purchase | 15.6K | $3.20 | $50K | 15.6K | View | |
| 2026-08-07 | 2026-08-11 | Lee-Sepsick Kathy | Director & Chief Executive Officer | Purchase | 15.6K | $3.20 | $50K | 15.6K | View | |
| 2026-08-07 | 2026-08-11 | Sipos Jeremy Alexander | Chief Technology Officer | Purchase | 3,125 | $3.20 | $10K | 3,125 | View | |
| 2026-08-07 | 2026-08-11 | Mifek Jeffrey Gerald | Chief Clinical-Medical Affairs | Purchase | 3,125 | $3.20 | $10K | 3,125 | View |
Informational purposes only, not investment advice.
tormere.com/research/FEMY · generated 2026-10-28
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-07 | Canning John Charles | P | 4,375 | $14,000 |
| 2026-08-07 | Elefant Dov | P | 15,625 | $50,000 |
| 2026-08-07 | Lee-Sepsick Kathy | P | 15,625 | $50,000 |
| 2026-08-07 | Sipos Jeremy Alexander | P | 3,125 | $10,000 |
| 2026-08-07 | Mifek Jeffrey Gerald | P | 3,125 | $10,000 |
Tormere — informational purposes only, not investment advice.